121 related articles for article (PubMed ID: 2873028)
41. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM).
Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H
Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680
[TBL] [Abstract][Full Text] [Related]
42. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
43. Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man.
Konturek SJ; Kwiecień N; Obtułowicz W; Bielański W; Oleksy J; Schally AV
Scand J Gastroenterol; 1985 Jan; 20(1):31-8. PubMed ID: 2859650
[TBL] [Abstract][Full Text] [Related]
44. Plasma somatostatin 28 increases in response to feeding in man.
Polonsky KS; Shoelson SE; Docherty HM
J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
[TBL] [Abstract][Full Text] [Related]
45. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
Rümenapf G; Hanisch E; Schwille PO
Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
[TBL] [Abstract][Full Text] [Related]
46. Plasma somatostatin and vasoactive intestinal polypeptide responses to an oral mixed test meal in obese patients.
Barreca T; Franceschini R; Messina V; Cataldi A; Salvemini M; Rolandi E
Horm Res; 1989; 31(5-6):234-7. PubMed ID: 2575574
[TBL] [Abstract][Full Text] [Related]
47. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid.
Fitz-Patrick D; Patel YC
J Clin Invest; 1979 Sep; 64(3):737-42. PubMed ID: 468988
[TBL] [Abstract][Full Text] [Related]
48. High plasma free fatty acid levels contribute to the hypersomatostatinemia of insulin deficiency.
Wasada T; Howard B; McCorkle K; Harris V; Unger RH
Diabetes; 1981 Apr; 30(4):358-61. PubMed ID: 6110603
[TBL] [Abstract][Full Text] [Related]
49. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
Levitt NS; Vinik AI; Child PT
J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
[TBL] [Abstract][Full Text] [Related]
50. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
[TBL] [Abstract][Full Text] [Related]
51. Postprandial glucose, insulin and glucagon responses to meals with different nutrient compositions in non-insulin-dependent diabetes mellitus.
Kawai K; Murayama Y; Okuda Y; Yamashita K
Endocrinol Jpn; 1987 Oct; 34(5):745-53. PubMed ID: 3325280
[TBL] [Abstract][Full Text] [Related]
52. Fasting plasma somatostatin in alcoholic liver disease.
Kelbaek H; Tronier B; Bahnsen M; Munkgaard S; Pedersen H
Scand J Clin Lab Invest; 1983 Nov; 43(7):597-601. PubMed ID: 6140748
[TBL] [Abstract][Full Text] [Related]
53. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
Taborsky GJ; Ensinck JW
J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
[TBL] [Abstract][Full Text] [Related]
54. Plasma levels of somatostatin following a test meal in dogs. Initial atropine resistant vagally mediated decrease of somatostatin levels and increase of gastrin and insulin levels.
Uvnäs-Moberg K; Andersson B; Posloncec B
Acta Physiol Scand; 1982 Feb; 114(2):253-9. PubMed ID: 6127867
[TBL] [Abstract][Full Text] [Related]
55. Plasma somatostatin response in normal and gastrectomized subjects.
Wasada T; Kodama Y; Inoue K; Hisatomi A; Sako Y; Ibayashi H
Tohoku J Exp Med; 1986 Oct; 150(2):181-8. PubMed ID: 2880412
[TBL] [Abstract][Full Text] [Related]
56. Endogenous digoxin-like immunoactivity in subjects with diabetes mellitus and hypertension.
Martinka E; Ocenásová A; Kamenistiaková L; Dobrota D; Kerný J; Mokán M
Am J Hypertens; 1998 Jun; 11(6 Pt 1):667-76. PubMed ID: 9657625
[TBL] [Abstract][Full Text] [Related]
57. Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus.
Hasegawa H; Shirohara H; Okabayashi Y; Nakamura T; Fujii M; Koide M; Otsuki M
Metabolism; 1996 Feb; 45(2):196-202. PubMed ID: 8596489
[TBL] [Abstract][Full Text] [Related]
58. Effect of guar intake on plasma somatostatin-like immunoreactivity in diabetic patients.
Shimoyama R; Uehara S; Itagaki Y; Izumiyama S; Hirayama A
Hokkaido Igaku Zasshi; 1982 Nov; 57(6):727-33. PubMed ID: 6134660
[TBL] [Abstract][Full Text] [Related]
59. Influence of streptozotocin-induced diabetes on the concentration of immunoreactive somatostatin in the retina and peripheral blood of the rat: effect of insulin treatment.
Ariznavarreta C; Fernandez-Durango R
J Endocrinol; 1987 Sep; 114(3):363-7. PubMed ID: 2889787
[TBL] [Abstract][Full Text] [Related]
60. Release of somatostatin-like immunoreactivity from the lower gut.
Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
